Alvotech (ALVO) Other financing activities (2023 - 2025)
Alvotech's (ALVO) quarterly Other financing activities came in at -$4.8 million in Q2 2025, down 1.59% on a YoY basis from -$4.9 million in Q2 2024, and down 200.0% quarter-over-quarter from $4.8 million in Q1 2025.
Analysis
Alvotech (ALVO) Other financing activities (2023 - 2025) Analysis & Trends
Alvotech (ALVO) has reported Other financing activities for 3 consecutive years, with -$4.8 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Other financing activities fell 1.59% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2025 stood at $76000.0 (changed N/A YoY), and the FY2024 full-year result was $76000.0, changed N/A from the prior year.
- Other financing activities declined to -$4.8 million in Q2 2025 per ALVO's latest filing, from $4.8 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.8 million in Q1 2024 and bottomed at -$6.4 million in Q4 2023.
- Historically, Other financing activities has averaged -$2.1 million across 3 years, with a median of -$4.8 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Other financing activities gained 25.14% in 2024, then declined 1.59% in 2025.
- Over 3 years, Other financing activities stood at -$6.4 million in 2023, then advanced by 25.43% to -$4.8 million in 2024, then decreased by 1.59% to -$4.8 million in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered -$4.8 million, $4.8 million, and -$4.8 million for Q2 2025, Q1 2025, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 4.84 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Mar 31, 2024 | 4.84 Mn |
| Dec 31, 2023 | -6.39 Mn |
| Jun 30, 2023 | -6.37 Mn |